There are many investors who are almost always on the lookout for high risk but high reward investments in the market and one of the stocks that could be a contender for such a player is the Vaxart (NASDAQ:VXRT) stock. The company has come into focus among many investors since it is has developed a COVID 19 vaccine candidate, which is a pill.
It is a product that is totally different from the other vaccines in the market and on top of that, not too long ago Vaxart also revealed positive results from the Phase 1 trial of the product.
Pills are far more convenient for most people who are not comfortable with needles. In addition to that, a COVID 19 vaccine pill is also going to be far cheaper since it is not going to involve the considerable costs of delivering the jabs. However, at the same time, it is also necessary to note that millions of people have already been vaccinated and even if the product is approved, it remains to be seen what sort of revenues the vaccine can bring in for Vaxart.
Market Action:
At the time of writing, VXRT stock gained by 8.50% to $7.14. The stock has seen a total volume of 2.67 million shares, above its average volume of 15.98 million shares.
 Stock Moves Back Above $7: What to Do Now?){kind=link}